AFA Blue-Green Algae.

Aphanizomenon flos-aquae and Arthrospira are both cyanobacteria, so both supply phycocyanin, chlorophyll, carotenoids and a high protein fraction. Blends carry them together to raise total pigment and protein per serving. The overlap means the pairing adds quantity rather than a new mechanism. It also means any cyanobacteria-specific caution, including cyanotoxin screening of the raw material, applies to both.

Chlorella is a eukaryotic green alga with a tough cellulose-containing wall that must be cracked, whereas AFA is a cyanobacterium with a fragile wall that ruptures easily. Blends combine them for a wider pigment and nutrient profile. The rationale is compositional coverage, not a measured interaction. Nothing in this ingredient's candidate set tests the pair.

Astaxanthin is a lipid-phase xanthophyll and phycocyanin is a water-soluble pigment protein, so the two partition into different compartments. Formulators pair them to cover both phases. The chemistry is coherent and the combination has not been measured in humans. This row describes partitioning, not a demonstrated effect.

Blue-green algae contain pseudovitamin B12, a corrinoid that binds human B12 transport proteins but does not serve as a cofactor for human B12-dependent enzymes. That makes algal B12 content misleading on a label and means the analogue can occupy binding capacity intended for the active vitamin. Anyone relying on an algal source for B12 needs a separate cyanocobalamin or methylcobalamin source. This is settled nutritional biochemistry for cyanobacteria as a class.

Cyanobacterial biomass carries non-heme iron bound within a protein and pigment matrix, so it enters the same absorption route as any plant-source iron and is subject to the same enhancers and inhibitors. Pairing with vitamin C raises non-heme uptake by keeping iron in the reduced form. The interaction sits at the absorption step and is characterised for non-heme iron generally rather than for this alga specifically.

Ascorbic acid reduces ferric iron to ferrous iron in the gut lumen and forms a soluble complex that survives the shift to intestinal pH. That raises absorption of non-heme iron from any plant or algal matrix. The mechanism is textbook and does not depend on a trial of this ingredient. It applies to the iron in the biomass, not to the pigments.

Phenylethylamine is formed by decarboxylation of phenylalanine, and it is the constituent most often cited behind this ingredient's mood framing. Supplying the amino acid precursor is the reason the two are stacked. Orally administered phenylethylamine is degraded rapidly by monoamine oxidase B, which limits how much reaches circulation. The biosynthetic step is established; the downstream effect on mood is not something this row claims.

Long-chain omega-3 fatty acids are oxidation-prone, and antioxidant-rich blends are often taken alongside them for that reason. AFA contributes water-soluble pigments and some alpha-linolenic acid. The pairing is formulation practice rather than a tested combination. Nothing measured in the candidate set speaks to it.

Carotenoids present in algal biomass compete with supplemental beta-carotene for micellar incorporation and the same intestinal transporters. A large single-carotenoid dose can lower the measured uptake of the others taken with it. This is an absorption-level competition documented across carotenoid pairs. It does not imply either carotenoid is displaced once in tissue.

Part of the cyanobacterial cell content resists digestion and reaches the colon, where resident and supplemented bacteria can ferment it. Green-food and probiotic blends are combined on that basis. The substrate step is plausible from general microbiology; no study confirms it for this species. Regard it as a rationale rather than a finding.